Logo image of RDI

READING INTERNATIONAL INC-A (RDI) Stock Fundamental Analysis

USA - NASDAQ:RDI - US7554081015 - Common Stock

1.39 USD
-0.04 (-2.7%)
Last: 10/13/2025, 4:04:05 PM
Fundamental Rating

1

Overall RDI gets a fundamental rating of 1 out of 10. We evaluated RDI against 79 industry peers in the Entertainment industry. RDI has a bad profitability rating. Also its financial health evaluation is rather negative. RDI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RDI had negative earnings in the past year.
RDI had a positive operating cash flow in the past year.
In the past 5 years RDI reported 4 times negative net income.
In the past 5 years RDI always reported negative operating cash flow.
RDI Yearly Net Income VS EBIT VS OCF VS FCFRDI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

RDI has a Return On Assets of -4.60%. This is in the lower half of the industry: RDI underperforms 62.03% of its industry peers.
Industry RankSector Rank
ROA -4.6%
ROE N/A
ROIC N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDI Yearly ROA, ROE, ROICRDI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

RDI's Gross Margin of 12.85% is on the low side compared to the rest of the industry. RDI is outperformed by 81.01% of its industry peers.
In the last couple of years the Gross Margin of RDI has declined.
The Profit Margin and Operating Margin are not available for RDI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
RDI Yearly Profit, Operating, Gross MarginsRDI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

0

2. Health

2.1 Basic Checks

RDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
RDI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RDI has more shares outstanding
Compared to 1 year ago, RDI has a worse debt to assets ratio.
RDI Yearly Shares OutstandingRDI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDI Yearly Total Debt VS Total AssetsRDI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

RDI has an Altman-Z score of -0.19. This is a bad value and indicates that RDI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.19, RDI is not doing good in the industry: 65.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.19
ROIC/WACCN/A
WACC8.25%
RDI Yearly LT Debt VS Equity VS FCFRDI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.16 indicates that RDI may have some problems paying its short term obligations.
RDI has a worse Current ratio (0.16) than 91.14% of its industry peers.
A Quick Ratio of 0.15 indicates that RDI may have some problems paying its short term obligations.
RDI's Quick ratio of 0.15 is on the low side compared to the rest of the industry. RDI is outperformed by 89.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.15
RDI Yearly Current Assets VS Current LiabilitesRDI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

RDI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.08%, which is quite impressive.
The Revenue has been growing slightly by 7.57% in the past year.
Measured over the past years, RDI shows a decrease in Revenue. The Revenue has been decreasing by -5.33% on average per year.
EPS 1Y (TTM)49.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)7.57%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%21.31%

3.2 Future

Based on estimates for the next years, RDI will show a very strong growth in Earnings Per Share. The EPS will grow by 26.41% on average per year.
The Revenue is expected to grow by 7.38% on average over the next years.
EPS Next Y64.19%
EPS Next 2Y35.75%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue Next Year7%
Revenue Next 2Y9.2%
Revenue Next 3Y7.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RDI Yearly Revenue VS EstimatesRDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RDI Yearly EPS VS EstimatesRDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDI Price Earnings VS Forward Price EarningsRDI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

RDI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.83
RDI Per share dataRDI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

RDI's earnings are expected to grow with 26.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.75%
EPS Next 3Y26.41%

More info and screens

0

5. Dividend

5.1 Amount

RDI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

READING INTERNATIONAL INC-A

NASDAQ:RDI (10/13/2025, 4:04:05 PM)

1.39

-0.04 (-2.7%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners45.82%
Inst Owner Change0%
Ins Owners6.25%
Ins Owner Change1.48%
Market Cap31.58M
Analysts80
Price Target2.55 (83.45%)
Short Float %0.63%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-31.69%
Min EPS beat(2)-112.16%
Max EPS beat(2)48.79%
EPS beat(4)2
Avg EPS beat(4)-35.24%
Min EPS beat(4)-114.64%
Max EPS beat(4)48.79%
EPS beat(8)2
Avg EPS beat(8)-381.47%
EPS beat(12)3
Avg EPS beat(12)-294.48%
EPS beat(16)4
Avg EPS beat(16)-225.8%
Revenue beat(2)0
Avg Revenue beat(2)-6.42%
Min Revenue beat(2)-7.5%
Max Revenue beat(2)-5.34%
Revenue beat(4)1
Avg Revenue beat(4)-2.89%
Min Revenue beat(4)-8.14%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-5.5%
Revenue beat(12)2
Avg Revenue beat(12)-6.46%
Revenue beat(16)4
Avg Revenue beat(16)-4.47%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-32.39%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF 9.95
P/B N/A
P/tB N/A
EV/EBITDA 23.83
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.14
OCFY10.05%
SpS9.65
BVpS-0.34
TBVpS-1.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.85%
FCFM N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 16.32
Cap/Depr 27.84%
Cap/Sales 1.82%
Interest Coverage N/A
Cash Conversion 38.66%
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.15
Altman-Z -0.19
F-Score6
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)34.68%
Cap/Depr(5y)51%
Cap/Sales(3y)3.09%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y64.19%
EPS Next 2Y35.75%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue 1Y (TTM)7.57%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%21.31%
Revenue Next Year7%
Revenue Next 2Y9.2%
Revenue Next 3Y7.38%
Revenue Next 5YN/A
EBIT growth 1Y65.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year219.92%
EBIT Next 3Y58.44%
EBIT Next 5YN/A
FCF growth 1Y96.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.03%
OCF growth 3YN/A
OCF growth 5YN/A